KN-62

CAT:
804-HY-13290-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
KN-62 - image 1

KN-62

  • Description:

    KN-62 is a selective and reversible inhibitor of calmodulin-dependent protein kinase II (CaMK-II) with a Ki of 0.9 μM for rat brain CaMK-II. KN-62 directly binds to the calmodulin binding site of CaMK-II. KN-62 displays noncompetitive antagonism at P2X7 receptors in HEK293 cells, with an IC50 value of approximately 15 nM.
  • UNSPSC:

    12352005
  • Target:

    CaMK; P2X Receptor
  • Type:

    Reference compound
  • Related Pathways:

    Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Metabolic Disease; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/KN-62.html
  • Purity:

    99.23
  • Solubility:

    DMSO : ≥ 100 mg/mL
  • Smiles:

    O=C (N1CCN (C2=CC=CC=C2) CC1) [C@H] (CC3=CC=C (C=C3) OS (=O) (C4=CC=CC5=C4C=CN=C5) =O) N (C) S (=O) (C6=CC=CC7=C6C=CN=C7) =O
  • Molecular Formula:

    C38H35N5O6S2
  • Molecular Weight:

    721.84
  • References & Citations:

    [1]Gargett CE, et al. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol. 1997 Apr;120 (8) :1483-90.|[2]Ravi RG, et al. Potent P2X7 Receptor Antagonists: Tyrosyl Derivatives Synthesized Using a Sequential Parallel Synthetic Approach. Drug Dev Res. 2001 Oct;54 (2) :75-87.|[3]Manosso LM, et al. Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:59-67.|[4]H Hidaka, et al. Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol. 1992;32:377-97.|[5]Miso Park, et al. Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production. Sci Rep. 2019 Aug 12;9 (1) :11587.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Isoform:

    CaMK II; P2X7 Receptor
  • CAS Number:

    127191-97-3